FDA has the regulatory authority to place a clinical trial on clinical hold if there is insufficient information provided in the Investigational Device Exemption (IDE) of Investigational New Drug (IND) application to show adequate safety of the trial. A clinical hold may also be placed on an ongoing trial if new information that raises questions of safety is obtained.
Clinical Hold
Share / Follow
Recent Blogs
Great New Companion Diagnostics E-Book Released Today
A valuable resource in a hot, but under-informed segment of the market
Oragene Clearance Shows DNA Stabilization is Class II
Clearance could have a significant impact on DTCG providers
My Screening Test for Screening Tests
Offering up a rare bit of regulatory certainty
The Abolish OIVD Act of 2011
A torches-and-pitchforks approach to LDT regulations
Glossary Terms
Investigational New Drug
(IND)